Cite

HARVARD Citation

    Hagiwara, S. et al. (2022). Clinical implication of immune checkpoint inhibitor on the chronic hepatitis B virus infection. Hepatology research. 52 (9), pp. 754-761. [Online]. 
  
Back to record